{ "schemaVersion": 1, "organisationId": "O-e3c34a7aab884111a5047136bfa466af", "slug": "twist-bioscience-corp", "name": "Twist Bioscience Corp", "updatedAt": "2026-10-02T12:52:29.575352Z", "sections": [ { "type": "OVERVIEW", "text": "Twist Bioscience is a synthetic-biology company that uses a silicon-based platform to synthesize DNA at scale. Its products include synthetic genes, oligo pools, DNA libraries and tools for next-generation sequencing; its portfolio also includes protein solutions and antibody-discovery products. The company reports one operating segment, with product revenue grouped into DNA synthesis and protein solutions, and NGS applications. [P16722189][P43565069][P145685367][P145685523]\n\nTwist serves customers across healthcare, chemicals and materials, food and agriculture, academic research, and technology. Its stated mission is to make synthetic DNA to improve health and sustainability. The company manufactures in Oregon and California, and its listed offices and sales coverage extend to Asia and Europe. [P79880417][https://www.twistbioscience.com/company/esg/environmental][P91757226][https://www.twistbioscience.com/contact]\n\nFor scale, Twist reported fiscal 2025 revenue of $376.6 million and 979 employees as of September 30, 2025. For the nine months ended June 30, 2026, it reported revenue of $332.8 million. [T1418209][https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm][T16672104]\n[P16722189][P43565069][P145685367][P145685523][P79880417][https://www.twistbioscience.com/company/esg/environmental][P91757226][https://www.twistbioscience.com/contact][T1418209][https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm][T16672104][https://www.twistbioscience.com/company/esg/environmental][https://www.twistbioscience.com/contact][https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm]", "updatedAt": "2026-10-02T12:52:29.575352Z" }, { "type": "PRODUCTS", "text": "Twist Bioscience’s products include synthetic genes, oligo pools, DNA libraries and gene fragments made using its silicon-based DNA synthesis platform. The company reports that its platform can synthesize more than 1 million oligonucleotides of up to 500 bases per chip. Gene products include clonal-perfect and non-clonal genes up to 5,000 base pairs; Twist also reports a gene-fragment error rate of 1 error per 7,500 nucleotides. [P16722189][P75369790] The company also offers custom oligo pools and gene-synthesis products. [https://www.twistbioscience.com/products/oligopools][https://www.twistbioscience.com/products/genes]\n\nIts NGS applications include target-enrichment probes, library-preparation kits and reagents, human-exome kits, and fixed, custom or customer-curated panels. Additional offerings include methylation detection products, FastHyb workflows, and RNA-sequencing solutions. [P34472992][P45720838][https://www.twistbioscience.com/products/ngs][https://www.twistbioscience.com/products/ngs/library-preparation/ngs-library-preparation-kits][https://www.twistbioscience.com/products/ngs/rna-sequencing-solutions] Protein-related products and services include antibody libraries and biologics-discovery services, synthetic RNA manufacture, antibody-protein expression and characterization assays; antibody library formats include VHH, Fab and scFv. [P145685328][P145685536][https://www.twistbioscience.com/products/antibody-discovery/in-vitro][https://www.twistbioscience.com/products/antibody-discovery/library-of-libraries]\n\nIn its FY2026 third-quarter filing, Twist grouped synthetic genes, oligo pools, DNA libraries and biopharma services under “DNA synthesis and protein solutions,” and renamed “NGS tools” as “NGS applications.” [P145685367] For the nine months ended June 30, 2026, DNA synthesis and protein solutions accounted for 48% of revenue ($160.9 million), while NGS applications accounted for 52% ($171.9 million). [T16672106]\n[P16722189][P75369790][P34472992][P45720838][P145685328][P145685536][P145685367][T16672106][https://www.twistbioscience.com/products/oligopools][https://www.twistbioscience.com/products/genes][https://www.twistbioscience.com/products/ngs][https://www.twistbioscience.com/products/ngs/library-preparation/ngs-library-preparation-kits][https://www.twistbioscience.com/products/ngs/rna-sequencing-solutions][https://www.twistbioscience.com/products/antibody-discovery/in-vitro][https://www.twistbioscience.com/products/antibody-discovery/library-of-libraries]", "updatedAt": "2026-10-02T12:52:29.575352Z" }, { "type": "GEOGRAPHY", "text": "Twist Bioscience’s customer sales are geographically reported by shipping destination. For the first nine months of FY2026, revenue was $199.9 million from the Americas (60%), $109.3 million from Europe, the Middle East and Africa (EMEA; 33%), and $23.5 million from Asia-Pacific (APAC; 7%). The Americas category includes the U.S., Canada, Mexico and South America; APAC includes markets such as Japan, China, South Korea, India, Singapore and Australia. [P145685363] In FY2025, revenue was $225.6 million from the Americas (60%), $124.2 million from EMEA (33%) and $26.8 million from APAC (7%). Separately, 42% of FY2025 revenue came from customers outside the U.S. [T3278849][P108225967]\n\nThe company’s listed facilities are leased. U.S. sites include Wilsonville, Oregon (general and administrative functions and manufacturing); South San Francisco, California (general and administrative, R&D and manufacturing); Brisbane, California (warehouse); Quincy, Massachusetts (general and administrative, R&D and manufacturing); and Carlsbad, California (sales and marketing). It also lists a Guangzhou, China site for general and administrative, sales and marketing, and supply-chain activities, and a Singapore sales and marketing office. [T12871952] Wilsonville houses all synthetic-biology production and exclusively makes the Express product line; South San Francisco manufactures a significant portion of the company’s next-generation sequencing products. [P91757226]\n\nAs of September 30, 2025, Twist reported 979 employees across the company, with counts by function but not by geography. [P112079258]\n[P145685363][T3278849][P108225967][T12871952][P91757226][P112079258]", "updatedAt": "2026-10-02T12:52:29.575352Z" }, { "type": "SEGMENTS", "text": "Twist Bioscience reports one operating and reportable segment, rather than separate segments for its product lines. Its chief operating decision maker reviews consolidated results and also examines revenue by product line, geography, and industry. [P145685523]\n\nFor FY2025, the latest completed fiscal year, product-line revenue was: NGS tools, 55%; synthetic genes, 30%; oligo pools, 6%; antibody discovery, 6%; and DNA libraries, 3%. These are revenue disaggregations, not separately reported segments. [T3769245]\n\nNGS tools include sequencing sample-preparation and target-enrichment products, such as library-preparation kits, exome kits, and fixed or custom panels. [P45592286][P8555342] Synthetic genes include manufactured DNA strands and gene fragments used in research and product development. [P71018980] Oligo pools are diverse collections of oligonucleotides used in applications including targeted sequencing and CRISPR editing. [P105490157] Antibody discovery comprises partner-focused discovery services, including library generation, screening, and antibody characterization. [P16836726][P24059034] DNA libraries are shown as a distinct revenue category, though the cited revenue disclosure does not provide a more specific definition. [T3769245]\n[P145685523][T3769245][P45592286][P8555342][P71018980][P105490157][P16836726][P24059034]", "updatedAt": "2026-10-02T12:52:29.575352Z" }, { "type": "HISTORY", "text": "Twist Bioscience was founded on April 15, 2013, by Emily Leproust, Bill Banyai and Bill Peck. By early 2016, it reported shipping synthetic DNA to more than 100 customers, and that year Microsoft ordered its DNA for digital-data-storage research. [https://www.twistbioscience.com/blog/company-news-updates/happy-dna-day][https://investors.twistbioscience.com/news-releases/news-release-details/twist-bioscience-completes-61-million-series-d-financing-and-20/][https://www.prnewswire.com/news-releases/twist-bioscience-announces-microsoft-purchase-of-its-synthetic-dna-for-digital-data-storage-research-300257967.html]\n\nIn 2017, Twist acquired Genome Compiler to add gene-design capabilities. In 2018, it launched exome and custom target-enrichment products, expanding into next-generation sequencing, and completed its initial public offering, with shares beginning to trade on Nasdaq under TWST. [https://www.prnewswire.com/news-releases/twist-bioscience-acquires-genome-compiler-to-add-gene-design-capabilities-300246636.html][https://www.businesswire.com/news/home/20180214005518/en/Twist-Bioscience-Launches-Exome-Custom-Target-Enrichment][https://investors.twistbioscience.com/news-releases/news-release-details/twist-bioscience-corporation-announces-pricing-initial-public]\n\nThe company launched long oligos in 2019 and joined the DNA Data Storage Alliance, reflecting its work in both DNA synthesis and data storage. In 2021, it acquired NGS library-preparation company iGenomX and entered an agreement to acquire antibody-discovery company Abveris, broadening its sequencing and biopharma offerings. [https://www.businesswire.com/news/home/20190729005200/en/Twist-Bioscience-Launches-Long-Oligos-to-Fuel-Drug-Development-DNA-Data-Storage-and-Gene-Editing-Research][https://investors.twistbioscience.com/news-releases/news-release-details/twist-bioscience-illumina-and-western-digital-form-alliance][https://www.nasdaq.com/press-release/twist-bioscience-acquires-ngs-library-preparation-maker-igenomx-2021-06-30][https://www.businesswire.com/news/home/20211122005744/en/Twist-Bioscience-Enters-into-Definitive-Agreement-to-Acquire-Abveris-Bolstering-Biopharma-Capabilities]\n\nIn 2025, Twist announced that its DNA-data-storage technology would be spun out into Atlas Data Storage; co-founder Bill Banyai moved to the new company as CTO. [https://investors.twistbioscience.com/news-releases/news-release-details/twist-bioscience-spins-out-dna-data-storage-independent-company/]", "updatedAt": "2026-10-02T12:52:29.575352Z" } ], "sources": [ { "id": "P16722189", "href": "https://app.finbar.com/go?id=P16722189", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "P43565069", "href": "https://app.finbar.com/go?id=P43565069", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "P145685367", "href": "https://app.finbar.com/go?id=P145685367", "label": "Twist Bioscience Corp — Full financial report (2026 Q 3)", "documentId": "D-9b9d4eaf3c86426aacaf018fb7354f27" }, { "id": "P145685523", "href": "https://app.finbar.com/go?id=P145685523", "label": "Twist Bioscience Corp — Full financial report (2026 Q 3)", "documentId": "D-9b9d4eaf3c86426aacaf018fb7354f27" }, { "id": "P79880417", "href": "https://app.finbar.com/go?id=P79880417", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "https://www.twistbioscience.com/company/esg/environmental", "href": "https://www.twistbioscience.com/company/esg/environmental", "label": "www.twistbioscience.com" }, { "id": "P91757226", "href": "https://app.finbar.com/go?id=P91757226", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "https://www.twistbioscience.com/contact", "href": "https://www.twistbioscience.com/contact", "label": "www.twistbioscience.com" }, { "id": "T1418209", "href": "https://app.finbar.com/go?id=T1418209", "label": "Twist Bioscience Corp — Press release (2025 Y)", "documentId": "D-4bd035d50c91446fa41c7a48c67c0136" }, { "id": "https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm", "href": "https://www.sec.gov/Archives/edgar/data/1581280/000158128025000025/twst-20250930.htm", "label": "www.sec.gov" }, { "id": "T16672104", "href": "https://app.finbar.com/go?id=T16672104", "label": "Twist Bioscience Corp — Full financial report (2026 Q 3)", "documentId": "D-9b9d4eaf3c86426aacaf018fb7354f27" }, { "id": "P75369790", "href": "https://app.finbar.com/go?id=P75369790", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "https://www.twistbioscience.com/products/oligopools", "href": "https://www.twistbioscience.com/products/oligopools", "label": "www.twistbioscience.com" }, { "id": "https://www.twistbioscience.com/products/genes", "href": "https://www.twistbioscience.com/products/genes", "label": "www.twistbioscience.com" }, { "id": "P34472992", "href": "https://app.finbar.com/go?id=P34472992", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "P45720838", "href": "https://app.finbar.com/go?id=P45720838", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "https://www.twistbioscience.com/products/ngs", "href": "https://www.twistbioscience.com/products/ngs", "label": "www.twistbioscience.com" }, { "id": "https://www.twistbioscience.com/products/ngs/library-preparation/ngs-library-preparation-kits", "href": "https://www.twistbioscience.com/products/ngs/library-preparation/ngs-library-preparation-kits", "label": "www.twistbioscience.com" }, { "id": "https://www.twistbioscience.com/products/ngs/rna-sequencing-solutions", "href": "https://www.twistbioscience.com/products/ngs/rna-sequencing-solutions", "label": "www.twistbioscience.com" }, { "id": "P145685328", "href": "https://app.finbar.com/go?id=P145685328", "label": "Twist Bioscience Corp — Full financial report (2026 Q 3)", "documentId": "D-9b9d4eaf3c86426aacaf018fb7354f27" }, { "id": "P145685536", "href": "https://app.finbar.com/go?id=P145685536", "label": "Twist Bioscience Corp — Full financial report (2026 Q 3)", "documentId": "D-9b9d4eaf3c86426aacaf018fb7354f27" }, { "id": "https://www.twistbioscience.com/products/antibody-discovery/in-vitro", "href": "https://www.twistbioscience.com/products/antibody-discovery/in-vitro", "label": "www.twistbioscience.com" }, { "id": "https://www.twistbioscience.com/products/antibody-discovery/library-of-libraries", "href": "https://www.twistbioscience.com/products/antibody-discovery/library-of-libraries", "label": "www.twistbioscience.com" }, { "id": "T16672106", "href": "https://app.finbar.com/go?id=T16672106", "label": "Twist Bioscience Corp — Full financial report (2026 Q 3)", "documentId": "D-9b9d4eaf3c86426aacaf018fb7354f27" }, { "id": "P145685363", "href": "https://app.finbar.com/go?id=P145685363", "label": "Twist Bioscience Corp — Full financial report (2026 Q 3)", "documentId": "D-9b9d4eaf3c86426aacaf018fb7354f27" }, { "id": "T3278849", "href": "https://app.finbar.com/go?id=T3278849", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "P108225967", "href": "https://app.finbar.com/go?id=P108225967", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "T12871952", "href": "https://app.finbar.com/go?id=T12871952", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "P112079258", "href": "https://app.finbar.com/go?id=P112079258", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "T3769245", "href": "https://app.finbar.com/go?id=T3769245", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "P45592286", "href": "https://app.finbar.com/go?id=P45592286", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "P8555342", "href": "https://app.finbar.com/go?id=P8555342", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "P71018980", "href": "https://app.finbar.com/go?id=P71018980", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "P105490157", "href": "https://app.finbar.com/go?id=P105490157", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "P16836726", "href": "https://app.finbar.com/go?id=P16836726", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "P24059034", "href": "https://app.finbar.com/go?id=P24059034", "label": "Twist Bioscience Corp — Full financial report (2025 Y)", "documentId": "D-2ea3c5029d5f45bc978f33612aef5ee5" }, { "id": "https://www.twistbioscience.com/blog/company-news-updates/happy-dna-day", "href": "https://www.twistbioscience.com/blog/company-news-updates/happy-dna-day", "label": "www.twistbioscience.com" }, { "id": "https://investors.twistbioscience.com/news-releases/news-release-details/twist-bioscience-completes-61-million-series-d-financing-and-20/", "href": "https://investors.twistbioscience.com/news-releases/news-release-details/twist-bioscience-completes-61-million-series-d-financing-and-20/", "label": "investors.twistbioscience.com" }, { "id": "https://www.prnewswire.com/news-releases/twist-bioscience-announces-microsoft-purchase-of-its-synthetic-dna-for-digital-data-storage-research-300257967.html", "href": "https://www.prnewswire.com/news-releases/twist-bioscience-announces-microsoft-purchase-of-its-synthetic-dna-for-digital-data-storage-research-300257967.html", "label": "www.prnewswire.com" }, { "id": "https://www.prnewswire.com/news-releases/twist-bioscience-acquires-genome-compiler-to-add-gene-design-capabilities-300246636.html", "href": "https://www.prnewswire.com/news-releases/twist-bioscience-acquires-genome-compiler-to-add-gene-design-capabilities-300246636.html", "label": "www.prnewswire.com" }, { "id": "https://www.businesswire.com/news/home/20180214005518/en/Twist-Bioscience-Launches-Exome-Custom-Target-Enrichment", "href": "https://www.businesswire.com/news/home/20180214005518/en/Twist-Bioscience-Launches-Exome-Custom-Target-Enrichment", "label": "www.businesswire.com" }, { "id": "https://investors.twistbioscience.com/news-releases/news-release-details/twist-bioscience-corporation-announces-pricing-initial-public", "href": "https://investors.twistbioscience.com/news-releases/news-release-details/twist-bioscience-corporation-announces-pricing-initial-public", "label": "investors.twistbioscience.com" }, { "id": "https://www.businesswire.com/news/home/20190729005200/en/Twist-Bioscience-Launches-Long-Oligos-to-Fuel-Drug-Development-DNA-Data-Storage-and-Gene-Editing-Research", "href": "https://www.businesswire.com/news/home/20190729005200/en/Twist-Bioscience-Launches-Long-Oligos-to-Fuel-Drug-Development-DNA-Data-Storage-and-Gene-Editing-Research", "label": "www.businesswire.com" }, { "id": "https://investors.twistbioscience.com/news-releases/news-release-details/twist-bioscience-illumina-and-western-digital-form-alliance", "href": "https://investors.twistbioscience.com/news-releases/news-release-details/twist-bioscience-illumina-and-western-digital-form-alliance", "label": "investors.twistbioscience.com" }, { "id": "https://www.nasdaq.com/press-release/twist-bioscience-acquires-ngs-library-preparation-maker-igenomx-2021-06-30", "href": "https://www.nasdaq.com/press-release/twist-bioscience-acquires-ngs-library-preparation-maker-igenomx-2021-06-30", "label": "www.nasdaq.com" }, { "id": "https://www.businesswire.com/news/home/20211122005744/en/Twist-Bioscience-Enters-into-Definitive-Agreement-to-Acquire-Abveris-Bolstering-Biopharma-Capabilities", "href": "https://www.businesswire.com/news/home/20211122005744/en/Twist-Bioscience-Enters-into-Definitive-Agreement-to-Acquire-Abveris-Bolstering-Biopharma-Capabilities", "label": "www.businesswire.com" }, { "id": "https://investors.twistbioscience.com/news-releases/news-release-details/twist-bioscience-spins-out-dna-data-storage-independent-company/", "href": "https://investors.twistbioscience.com/news-releases/news-release-details/twist-bioscience-spins-out-dna-data-storage-independent-company/", "label": "investors.twistbioscience.com" } ] }